# Careseng 1370 for Healthy Volunteers

> **NCT03974516** · PHASE1 · TERMINATED · sponsor: **i Cure Biotech Co., Ltd.** · enrollment: 13 (actual)

## Conditions studied

- Chemotherapy-induced Myelosuppression

## Interventions

- **DRUG:** Careseng 1370

## Key facts

- **NCT ID:** NCT03974516
- **Lead sponsor:** i Cure Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-10
- **Primary completion:** 2022-03-11
- **Final completion:** 2022-03-11
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** This study was early terminated by the sponsor considering the difficulty of subject recruitment in the pandemic of COVID-19.
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03974516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03974516, "Careseng 1370 for Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03974516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*